Early Structural Valve Deterioration of the Mitroflow Aortic Bioprosthesis: Will the New Anticalcification Treatment Change Anything?

Abstract

1997 There has been a trend toward more frequent use of bioprosthetic valves, especially in the young generations, over the last decade. According to the Society of Thoracic Surgeons database, use of bioprosthetic valve increased from 44% in 1996 to 78% in 2006 in North America. Freedom from warfarin use and restrictions on diet and activities make bioprosthetic valves more attractive and popular, and multiple reports have shown that choosing a bioprosthetic valve does not decrease survival despite the increased rate of reoperation.

DOI: 10.1016/j.rec.2017.08.008

Cite this paper

@article{BlascoLucas2014EarlySV, title={Early Structural Valve Deterioration of the Mitroflow Aortic Bioprosthesis: Will the New Anticalcification Treatment Change Anything?}, author={Arnau Blasco-Lucas and Jos{\'e} Manuel Rabasa and Daniel R. Ortiz and Albert Miralles}, journal={Revista espanola de cardiologia}, year={2014} }